Turku University Hospital

🇫🇮Finland

Country: 🇫🇮Finland

Ownership: Subsidiary

Established: 1756-01-01

Employees: -

Market Cap: -

Website: http://www.vsshp.fi

Clinical Trials

Premedication With Intranasal Dexmedetomidine in Sedation of Patients Undergoing Total Knee Arthroplasty

Phase 4

Active, not recruiting

Conditions: Knee Osteoarthritis
Pain, Postoperative

Interventions: Drug: Dexmedetomidine
Drug: Placebo

First Posted Date: 2021-04-26

Last Posted Date: 2024-11-11

Lead Sponsor: Turku University Hospital

Target Recruit Count: 100

Registration Number: NCT04859283

Locations: 🇫🇮
Perioperative Services, Intensive Care and Pain Therapy, Turku University Hospital and University of Turku, Turku, Finland

Interaction of Sleep, Diurnal Eating Pattern, Gut Microbiota, and Obesity

Not Applicable

Recruiting

Conditions: Obesity

Interventions: Other: Mobile app

First Posted Date: 2021-04-20

Last Posted Date: 2022-06-16

Lead Sponsor: Turku University Hospital

Target Recruit Count: 120

Registration Number: NCT04850391

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC

Recruiting

Conditions: High Grade Ovarian Serous Adenocarcinoma
High Grade Serous Carcinoma

Interventions: Genetic: WGS and RNA sequencing
Genetic: circulating tumor DNA (ctDNA)
Diagnostic Test: FDG PET/CT imaging

First Posted Date: 2021-04-15

Last Posted Date: 2023-06-18

Lead Sponsor: Turku University Hospital

Target Recruit Count: 200

Registration Number: NCT04846933

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Open-Label Prospective Study Comparing Long-Term Outcome With or Without HFNC in Patients With Stable Hypercapnic COPD

Not Applicable

Conditions: COPD

Interventions: Device: HFNC Airvo
Other: Standard care

First Posted Date: 2021-04-12

Last Posted Date: 2022-06-16

Lead Sponsor: Turku University Hospital

Target Recruit Count: 94

Registration Number: NCT04840706

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Auditory Environment by Parents of Preterm Infants

Conditions: Infant Development
Language Development
Preterm Birth

First Posted Date: 2021-04-01

Last Posted Date: 2021-05-05

Lead Sponsor: Turku University Hospital

Target Recruit Count: 116

Registration Number: NCT04826978

Ethanol-induced Vestibular Dysfunction as a Model for Bilateral Vestibular Syndrome.

Not Applicable

Conditions: vHIT- and VOG-model for Bilateral Vestibular Neuronitis

Interventions: Other: Ethanol

First Posted Date: 2021-03-05

Last Posted Date: 2021-03-05

Lead Sponsor: Turku University Hospital

Target Recruit Count: 10

Registration Number: NCT04783610

EVLA and Optimal Timing of Sclerotherapy

Not Applicable

Not yet recruiting

Conditions: Venous Reflux

Interventions: Procedure: Endovenous laser ablation

First Posted Date: 2021-03-01

Last Posted Date: 2021-03-01

Lead Sponsor: Turku University Hospital

Target Recruit Count: 350

Registration Number: NCT04774939

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Bioactive Glass or Allogenic Bone in Pediatric Bone Cysts

Not Applicable

Conditions: Bone Cysts

Interventions: Device: Bioactive glass

First Posted Date: 2021-02-04

Last Posted Date: 2021-02-04

Lead Sponsor: Turku University Hospital

Target Recruit Count: 40

Registration Number: NCT04737590

Locations: 🇫🇮
Oulu University Hospital, Oulu, Finland
🇫🇮
Helsinki University Hospital, Helsinki, Finland
🇫🇮
Kuopio University Hospital, Kuopio, Finland

and more 2 locations

PET-imaging of Unruptured Intracranial Aneurysm Inflammation

Not Applicable

Conditions: Intracranial Aneurysm
Inflammation
Cerebral Aneurysm

Interventions: Radiation: PET imaging, 18F-FDG
Radiation: PET imaging, 68Ga-DOTANOC

First Posted Date: 2021-01-20

Last Posted Date: 2021-01-20

Lead Sponsor: Turku University Hospital

Target Recruit Count: 20

Registration Number: NCT04715503

Locations: 🇫🇮
Turku University Hospital, Turku, Finland

Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage

Phase 2

Not yet recruiting

Conditions: Subarachnoid Hemorrhage, Aneurysmal
Cerebral Injury
Cerebral Ischemia
Cerebral Infarction
Cardiac Event
Cardiac Failure

Interventions: Drug: air/oxygen
Drug: Xenon

First Posted Date: 2021-01-06

Last Posted Date: 2023-04-19

Lead Sponsor: Turku University Hospital

Target Recruit Count: 160

Registration Number: NCT04696523

Locations: 🇫🇮
Kuopio University Hospital, Kuopio, Finland
🇫🇮
Elomatic, Turku, Finland
🇫🇮
Aalto University School of Science, Helsinki, Finland

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy